Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: Libbyt who wrote (49338)	12/10/2003 12:18:09 AM
From: tuck	Read Replies (2) \| Respond to of 57110

Now leaning towards short on MEDI. For one, Chiron is offering to up production of its flu vaccine. For another, there are various marketing and logistical problems associated with this launch (the current version may offer broader protection, but the distributor needs a freezer), as evidenced by the following post, whose author I am personally acquainted with. Message 19579723 I think they've blown it for this year. Next season is another matter. Aside to Jorj: Sorry, don't know diddly about VION. Doesn't look as though they have much cash. The recent payment by Chinese distributor will help a little, but the drug in question is only in Phase II. Kind of early to be lining up the vendors. I don't know the drug, and couldn't say what its chances might be. I don't think it's partnered with a cash rich pharma, so the trials are likely to be small, and the results heavily spun. Trade away with your charts, but my gut, operating with little information, says be careful in the longer haul. Cheers, Tuck